GNH USA

Europe — EMA

Olanzapina Cinfa (Olanzapine)

Olanzapine, the active ingredient in Olanzapina Cinfa, is an atypical antipsychotic presented as a solid oral dosage form for oral use. It treats schizophrenia and bipolar disorder in adult patients.

Request sourcing

1
Pack/s

What is Olanzapine?

Olanzapine, the active ingredient in Olanzapina Cinfa, is an atypical antipsychotic presented as a solid oral dosage form for oral use. It treats schizophrenia and bipolar disorder in adult patients. GNH USA supplies Olanzapina Cinfa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olanzapina Cinfa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olanzapine used for?

Olanzapina Cinfa is an atypical antipsychotic that modulates neurotransmission in psychotic and mood disorders.

- Schizophrenia: helps to reduce the frequency and severity of psychotic episodes including delusions and hallucinations. - Bipolar I Disorder (Manic Episodes): assists in controlling mania and stabilising mood fluctu ations. - Maintenance Therapy : provides long‑term symptom control to prevent relapse of schizophrenia or bipolar disorder. - Acute Ac  ??  ??  ??  -  ??  ??  - …  … ... … … 

What are the side effects of Olanzapine?

The     …  … … ....  … 

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Olanzapine
Route
Oral Use
Manufacturer
Laboratorios Cinfa S.A.
Origin
EU

Related products